Dose Response Study of a Topical Formulation of Nitroglycerin for the Treatment of Raynaud's Phenomenon
Status:
Completed
Trial end date:
2007-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this clinical study is to determine the response to two different dosage
strengths of a topical nitroglycerin gel in patients with Raynaud's Phenomenon. Patient
fingers will be monitored for changes in blood flow and skin temperature. Symptoms of pain,
tingling and numbness will also be monitored.